πŸ‡ΊπŸ‡Έ FDA
Patent

US 10807987

Heterocyclic compound and use thereof

granted A61KA61K9/2095A61K9/4833

Quick answer

US patent 10807987 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K9/2095, A61K9/4833, A61P, A61P25/00